--- a
+++ b/clusters/9knumclustersv2/clust_1000.txt
@@ -0,0 +1,47 @@
+Active infection, known human immunodeficiency virus infection, or positive test for hepatitis B surface antigen or hepatitis C.
+Any known human immunodeficiency virus (HIV) infection, hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Known hepatitis B surface antigen-positive or known or suspected active hepatitis C infection.
+Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection.
+Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection.
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
+Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
+Known to be positive for hepatitis B by surface antigen expression; known to have active hepatitis C infection (positive by polymerase chain reaction or on antiviral therapy for hepatitis C within the last  months)
+Known or suspected active hepatitis B or C infection
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis\r\nC infection
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
+Patients known to be positive for hepatitis B surface antigen expression or with active hepatitis C infection (positive by polymerase chain reaction or on antiviral therapy for hepatitis C within the last  months), or with known human immunodeficiency virus (HIV) infection
+Known to be positive for hepatitis B by surface antigen expression; known to have active hepatitis C infection (positive by polymerase chain reaction or on antiviral therapy for hepatitis C within the last  months)
+Known hepatitis B surface antigen-positive, known or suspected active hepatitis C infection (testing not required).
+Patients with known history of hepatitis B surface antigen-positive, or known history or suspected active hepatitis C infection are not to be enrolled in the study
+Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Patient is known to be hepatitis B surface antigen-positive or has known active hepatitis C infection.
+Patients who are known hepatitis B surface antigen-positive are not eligible
+Patients who have known or suspected active hepatitis C infections are not eligible; NOTE: patients who are hepatitis C surface antigen-positive are eligible
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection.
+Patients known to be positive for hepatitis B by surface antigen expression; known to have active hepatitis C infection (positive by polymerase chain reaction or on antiviral therapy for hepatitis C within the last  months)
+known or suspected past hepatitis B infection,
+Known human immunodeficiency virus (HIV) positive, hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection.
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
+Ongoing or active infection, known HIV positive, known to be hepatitis B surface antigen-positive or has known or suspected active hepatitis C infection.
+Known or suspected human immunodeficiency virus (HIV), hepatitis B surface antigen-positive status or known or suspected active hepatitis C infection.
+Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Patients who are known to be hepatitis B surface antigen positive.
+Known to be positive for hepatitis B by surface antigen expression; known to have active hepatitis C infection (positive by polymerase chain reaction or on antiviral therapy for hepatitis C within the last  months); known to be active cytomegalovirus (CMV) infection or herpes zoster infection
+Subject with known hepatitis B surface antigen (HBsAg) positive status; or known or suspected active hepatitis C infection; or known human immunodeficiency virus (HIV) positive.
+Known hepatitis B surface antigen positive or known or suspected active hepatitis C infection.
+Known to be positive for hepatitis B by surface antigen expression
+Known human immunodeficiency virus (HIV) positive or hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
+Known active hepatic disease (known hepatic cirrhosis, hepatitis B surface antigen positive status, or suspected active hepatitis C infection)
+Known active hepatic disease (known hepatic cirrhosis, hepatitis B surface antigen positive status, or suspected active hepatitis C infection)
+Known human immunodeficiency virus (HIV) positive, hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Has Known human immunodeficiency virus (HIV) positive, hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
+Patient has known or suspected HIV, positive for hepatitis B or is known or suspected to have active hepatitis C infection.
+Known HIV positive, hepatitis B surface antigen positive or known or suspected active hepatitis C infection.
+Known hepatitis B surface antigen positive, or known or suspected active hepatitis C infection.
+Known hepatitis B surface antigen-positive or known or suspected active hepatitis C infection (testing not required).